Insights

Global GMP footprint Leverage Eurofins BioPharma Product Testing North America's expansive North American network and global GMP standards to position as a preferred testing partner for multinational pharma and medical device clients seeking harmonized, quality-assured services.

Expanding capabilities Capitalize on recent expansions in Ontario Mississauga and broader North America to target biotech clusters and mid to late-stage development programs that require scalable lab capacity, HPAPI development, and kilolab capabilities.

Integrated services Promote end-to-end testing across drug substance, intermediates, starting materials and final products within GMP, ISO aligned frameworks, offering time-to-insight efficiencies through centralized LIMS and secure data access.

Advanced analytics Highlight new capabilities such as Dynamic Light Scattering and expanded particle size analysis to attract CMO/CDMO clients needing comprehensive characterization for nanomaterials, formulations, and quality control.

Strategic partnerships Position as a trusted partner for large pharmaceutical ecosystems and supply chain players by referencing ongoing collaborations and potential synergies with Kaneka and other biotech manufacturers requiring third-party testing and analytics.

Similar companies to Eurofins BioPharma Product Testing North America

Eurofins BioPharma Product Testing North America Tech Stack

Eurofins BioPharma Product Testing North America uses 8 technology products and services including SAS, WordPress, Azure DevOps, and more. Explore Eurofins BioPharma Product Testing North America's tech stack below.

Media & News

Eurofins BioPharma Product Testing North America's Email Address Formats

Eurofins BioPharma Product Testing North America uses at least 8 email formats:
Eurofins BioPharma Product Testing North America Email FormatsExamplePercentage
FirstLast@eurofinsus.comJohnDoe@eurofinsus.com
93%
FirLast@eurofinsus.comJohDoe@eurofinsus.com
3%
FLast@eurofinsus.comJDoe@eurofinsus.com
3%
FirstLas@eurofinsus.comJohnDoe@eurofinsus.com
1%
FirstLast@eurofins.comJohnDoe@eurofins.com
93%
FirLast@eurofins.comJohDoe@eurofins.com
3%
FirstMiddleLast@eurofins.comJohnMichaelDoe@eurofins.com
2%
FirstLas@eurofins.comJohnDoe@eurofins.com
2%

Frequently Asked Questions

What is Eurofins BioPharma Product Testing North America's official website and social media links?

Minus sign iconPlus sign icon
Eurofins BioPharma Product Testing North America's official website is eurofins.com and has social profiles on LinkedIn.

How much revenue does Eurofins BioPharma Product Testing North America generate?

Minus sign iconPlus sign icon
As of October 2026, Eurofins BioPharma Product Testing North America's annual revenue is estimated to be $250M - $500M.

What is Eurofins BioPharma Product Testing North America's SIC code and NAICS code?

Minus sign iconPlus sign icon
Eurofins BioPharma Product Testing North America's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eurofins BioPharma Product Testing North America have currently?

Minus sign iconPlus sign icon
As of October 2026, Eurofins BioPharma Product Testing North America has approximately 676 employees across 5 continents, including North America, Asia and Europe. Key team members include Chief Executive Officer: E. R., Chief Executive Officer: M. D. and Chief Executive Officer: R. H. Explore Eurofins BioPharma Product Testing North America's employee directory with LeadIQ.

What industry does Eurofins BioPharma Product Testing North America belong to?

Minus sign iconPlus sign icon
Eurofins BioPharma Product Testing North America operates in the Biotechnology Research industry.

What technology does Eurofins BioPharma Product Testing North America use?

Minus sign iconPlus sign icon
Eurofins BioPharma Product Testing North America's tech stack includes SAS, WordPress, Azure DevOps, VMware vCenter, BMC Remedy, PayPal, Box and Citrix.

What is Eurofins BioPharma Product Testing North America's email format?

Minus sign iconPlus sign icon
Eurofins BioPharma Product Testing North America's email format typically follows the pattern of FirstLast@eurofinsus.com. Find more Eurofins BioPharma Product Testing North America email formats with LeadIQ.
Eurofins BioPharma Product Testing North America logo

Eurofins BioPharma Product Testing North America

Biotechnology ResearchPennsylvania, United States501-1000 Employees

Eurofins BioPharma Product Testing North America provides GMP-compliant laboratory testing for drug substances, final products, intermediates, and starting materials for both small- and large-molecule drug products. Its client base includes the world's largest pharmaceutical, biopharmaceutical, and medical device companies, supported by a global network that underpins development and quality assurance. Analyses are conducted under GMP authorization and through ISO accreditation, following major pharmacopoeias and customer methods.

The organization operates a global network with substantial capacity across 59 countries and more than 45 locations, with seven key U.S. sites including Lancaster, Portage, Columbia, Cary, Charlotte, Jacksonville, and San Diego. It offers flexible service models, including insourcing solutions, and provides secure 24-hour data access through LabAccess.com. A recent development in the broader Eurofins network involved a January 2026 partnership with Eurofins QTA Inc.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
501-1000

Section iconFunding & Financials

  • $250M - $500M

    Eurofins BioPharma Product Testing North America's revenue is estimated to be in the range of $250M - $500M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.